Reports

HPV Associated Disorders Market

Global HPV Associated Disorders Market Size, Forecast: By Indication: Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts, Others; By Therapy: Prevention, Treatment; By Distributional Channel: Hospital Pharmacies, Others; Regional Analysis; Competitive Landscape; 2024-2032

Global HPV Associated Disorders Market Outlook

The global HPV associated disorders market was estimated at almost USD 18.52 billion in 2023. The industry is further expected to grow at a CAGR of 5% during the forecast period of 2024-2032.

 

Global HPV Associated Disorders Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

With the increase in the incidences of HPV-related diseases and the improvement in its treatment procedures, the global HPV associated disorders industry is expected to witness a steady growth over the forecast period.

 

Market Segmentation

HPV is a viral infection that often triggers the growth of the skin or mucous membrane (warts). There are over 100 human papillomaviruses (HPV) varieties. Many forms of cancers have been related to HPV infection, including anus, penis, uterus, vulva, and back of the throat (oropharyngeal).

 

Global HPV Associated Disorders Market By Indication

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global HPV associated disorders industry can be broadly categorised based on segments like indication, therapy, distributional channel, and region.

  • Indication:
    • Cervical Intraepithelial Neoplasia (CIN)
    • Cervical Cancer
    • Anal Intraepithelial Neoplasia (AIN)
    • Anal Cancer
    • Genital Warts
    • Others 
  • Therapy: 
    • Prevention
    • Treatment
  • Distributional Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

The EMR report looks into the regional HPV associated disorders markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global HPV Associated Disorders Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The increased government initiatives and the growing funding for cancer research are expected to aid the global HPV associated disorders industry. However, the increased investment in R&D associated with oncologic diseases offers significant growth opportunities for the industry growth in the future. The lack of knowledge regarding the diagnosis and treatment of such diseases and the high treatment costs are some factors that may hinder the industry growth over the forecast period.
 
Hospital pharmacies, among other distribution channels, are expected to account for the largest share in the industry owing to the growing expenditure in healthcare infrastructure in both the developing and underdeveloped economies. Region-wise, while North America leads the industry, the Asia Pacific is expected to grow at the highest CAGR over the forecast period owing to the development in the healthcare infrastructure in the region, along with the rising consumer expenditure power. 

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global HPV associated disorders industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche AG
  • Merck & Co., Inc. 
  • GlaxoSmithKline plc
  • Biocon Limited
  • AstraZeneca plc
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Indication, Therapy, Distribution Channel, Region
Breakup by Indication Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts, Others
Breakup by Therapy Prevention, Treatment
Breakup by Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered F. Hoffmann-La Roche AG, Merck & Co., Inc. , GlaxoSmithKline plc, Biocon Limited, AstraZeneca plc, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global HPV Associated Disorders Market Analysis

    8.1    Key Industry Highlights
    8.2    Global HPV Associated Disorders Historical Market (2018-2023) 
    8.3    Global HPV Associated Disorders Market Forecast (2024-2032)
    8.4    Global HPV Associated Disorders Market by Indication
        8.4.1    Cervical Intraepithelial Neoplasia (CIN)
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2023)
            8.4.1.3    Forecast Trend (2024-2032)
        8.4.2    Cervical Cancer
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2023)
            8.4.2.3    Forecast Trend (2024-2032)
        8.4.3    Anal Intraepithelial Neoplasia (AIN)
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2023)
            8.4.3.3    Forecast Trend (2024-2032)
        8.4.4    Anal Cancer
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2018-2023)
            8.4.4.3    Forecast Trend (2024-2032)
        8.4.5    Genital Warts
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2018-2023)
            8.4.5.3    Forecast Trend (2024-2032)
        8.4.6    Others
    8.5    Global HPV Associated Disorders Market by Therapy
        8.5.1    Prevention
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2023)
            8.5.1.3    Forecast Trend (2024-2032)
        8.5.2    Treatment
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2023)
            8.5.2.3    Forecast Trend (2024-2032)
    8.6    Global HPV Associated Disorders Market by Distribution Channel
        8.6.1    Hospital Pharmacies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2023)
            8.6.1.3    Forecast Trend (2024-2032)
        8.6.2    Retail Pharmacies
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2023)
            8.6.2.3    Forecast Trend (2024-2032)
        8.6.3    Online Pharmacies
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2023)
            8.6.3.3    Forecast Trend (2024-2032) 
8.7    Global HPV Associated Disorders Market by Region
        8.7.1    North America
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2023)
            8.7.1.3    Forecast Trend (2024-2032)
        8.7.2    Europe
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2023)
            8.7.2.3    Forecast Trend (2024-2032)
        8.7.3    Asia Pacific
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2018-2023)
            8.7.3.3    Forecast Trend (2024-2032)
        8.7.4    Latin America
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2018-2023)
            8.7.4.3    Forecast Trend (2024-2032)
        8.7.5    Middle East and Africa
            8.7.5.1    Market Share
            8.7.5.2    Historical Trend (2018-2023)
            8.7.5.3    Forecast Trend (2024-2032)
9    North America HPV Associated Disorders Market Analysis
    9.1    United States of America
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2023)
        9.1.3    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2023)
        9.2.3    Forecast Trend (2024-2032)
10    Europe HPV Associated Disorders Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2023)
        10.1.3    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2023)
        10.2.3    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2023)
        10.3.3    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2023)
        10.4.3    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific HPV Associated Disorders Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2023)
        11.1.3    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2023)
        11.2.3    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2023)
        11.3.3    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2023)
        11.4.3    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2023)
        11.5.3    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America HPV Associated Disorders Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2023)
        12.1.3    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2023)
        12.2.3    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2023)
        12.3.3    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa HPV Associated Disorders Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2023)
        13.1.3    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2023)
        13.2.3    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2023)
        13.3.3    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2023)
        13.4.3    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive  Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    F. Hoffmann-La Roche AG
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Merck & Co., Inc.
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    GlaxoSmithKline plc
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Biocon Limited.
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    AstraZeneca plc
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Others
17    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global HPV Associated Disorders Market: Key Industry Highlights, 2018 and 2032
2.    Global HPV Associated Disorders Historical Market: Breakup by Indication (USD Billion), 2018-2023
3.    Global HPV Associated Disorders Market Forecast: Breakup by Indication (USD Billion), 2024-2032
4.    Global HPV Associated Disorders Historical Market: Breakup by Therapy (USD Billion), 2018-2023
5.    Global HPV Associated Disorders Market Forecast: Breakup by Therapy (USD Billion), 2024-2032
6.    Global HPV Associated Disorders Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
7.    Global HPV Associated Disorders Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
8.    Global HPV Associated Disorders Historical Market: Breakup by Region (USD Billion), 2018-2023
9.    Global HPV Associated Disorders Market Forecast: Breakup by Region (USD Billion), 2024-2032
10.    North America HPV Associated Disorders Historical Market: Breakup by Country (USD Billion), 2018-2023
11.    North America HPV Associated Disorders Market Forecast: Breakup by Country (USD Billion), 2024-2032
12.    Europe HPV Associated Disorders Historical Market: Breakup by Country (USD Billion), 2018-2023
13.    Europe HPV Associated Disorders Market Forecast: Breakup by Country (USD Billion), 2024-2032
14.    Asia Pacific HPV Associated Disorders Historical Market: Breakup by Country (USD Billion), 2018-2023
15.    Asia Pacific HPV Associated Disorders Market Forecast: Breakup by Country (USD Billion), 2024-2032
16.    Latin America HPV Associated Disorders Historical Market: Breakup by Country (USD Billion), 2018-2023
17.    Latin America HPV Associated Disorders Market Forecast: Breakup by Country (USD Billion), 2024-2032
18.    Middle East and Africa HPV Associated Disorders Historical Market: Breakup by Country (USD Billion), 2018-2023
19.    Middle East and Africa HPV Associated Disorders Market Forecast: Breakup by Country (USD Billion), 2024-2032
20.    Global HPV Associated Disorders Market Structure

Key Questions Answered in the Report

The global HPV associated disorders market reached a value of USD 18.52 billion in 2023.

The market is projected to grow at a CAGR of nearly 5% in the forecast period of 2024-2032.

The major drivers of the industry include rising disposable incomes, increasing population, rising investment in R&D, and the growing expenditure in the healthcare infrastructure.

The increased government initiatives and the rising funding for cancer research are expected to be the key trends guiding the growth of the industry.

North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market, with North America dominating the market.

The leading indications segments in the industry include cervical intraepithelial neoplasia (CIN), cervical cancer, anal intraepithelial neoplasia (AIN), anal cancer, and genital warts, among others.

The major therapies included in the market are prevention and treatment.

The significant distribution channels in the industry include hospital pharmacies, retail pharmacies, and online pharmacies.

The leading players in the market are F. Hoffmann-La Roche AG, Merck & Co., Inc., GlaxoSmithKline plc, Biocon Limited, and AstraZeneca plc, among others.

Analyst Review

The global HPV associated disorders market attained a value of USD 18.52 billion in 2023, driven by the rising healthcare infrastructure. Aided by the increased government initiatives supporting the growth of the healthcare sector, the industry is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 5%.

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on indication, the global market for HPV associated disorders can be segmented into cervical intraepithelial neoplasia (CIN), cervical cancer, anal intraepithelial neoplasia (AIN), anal cancer, and genital warts, among others. By therapy, the industry can be segmented into prevention and treatment. On the basis of distribution channels, the industry can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The major regional markets for HPV associated disorders are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include F. Hoffmann-La Roche AG, Merck & Co., Inc. , GlaxoSmithKline plc, Biocon Limited, and AstraZeneca plc, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2799
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER